A Study to Learn if Study Medicines Called Cyclosporine and Clarithromycin Affect How the Body Processes the Other Study Medicine Called PF-07328948 in Healthy Adults

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 19, 2025

Primary Completion Date

June 11, 2025

Study Completion Date

June 11, 2025

Conditions

Healthy Adults

Interventions

DRUG

PF-07328948

single oral dose day 1 and day 12 (Part A) and day 4 (part B)

DRUG

cyclosporine

600 mg capsule day 12 (Part A)

DRUG

clarithromycin

500 mg tablets twice daily day 1 to day 6 (Part B)

Trial Locations (1)

Pfizer Clinical Research Unit - Brussels, Brussels